학술논문
Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report.
Document Type
Article
Author
Source
Subject
*RITUXIMAB
*B cells
*HODGKIN'S disease in children
*THERAPEUTICS
*
*
*
Language
ISSN
0887-6924
Abstract
A letter to the editor is presented regarding the effectiveness of rituximab with multiagent chemotherapy regimens in the treatment of advanced mature B-cell non-Hodgkin lymphoma (B-NHL) in children and adolescents.